港股异动 | 科济药业-B(02171)涨近6% 近日攻关实体瘤免疫细胞治疗新药项目获列入国家科技重大专项

智通财经01-05

智通财经APP获悉，科济药业-B(02171)涨近6%，截至发稿，涨5.94%，报16.23港元，成交额1880.74万港元。消息面上，12月30日，据科济药业官微消息，公司宣布，由旗下上海科济制药有限公司牵头申报的“实体肿瘤的免疫细胞治疗关键技术和创新药研发”项目，正式获批列入创新药物研发国家科技重大专项2025年度项目立项清单。据悉，国家科技重大专项是我国在战略前沿领域布局的最高层次科研...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2601071458?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-01-05 11:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601071458","market":"fut","top_or_hot":-1,"title":"港股异动 | 科济药业-B(02171)涨近6% 近日攻关实体瘤免疫细胞治疗新药 项目获列入国家科技重大专项","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，科济药业-B(02171)涨近6%，截至发稿，涨5.94%，报16.23港元，成交额1880.74万港元。消息面上，12月30日，据科济药业官微消息，公司宣布，由旗下上海科济制药有限公司牵头申报的“实体肿瘤的免疫细胞治疗关键技术和 创新药 研发”项目，正式获批列入创新药物研发国家科技重大专项2025年度项目立项清单。据悉，国家科技重大专项是我国在战略前沿领域布局的最高层次科研...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1388505.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 科济药业-B(02171)涨近6% 近日攻关实体瘤免疫细胞治疗新药 项目获列入国家科技重大专项</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 科济药业-B(02171)涨近6% 近日攻关实体瘤免疫细胞治疗新药 项目获列入国家科技重大专项\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-05 11:21 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1388505.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，科济药业-B(02171)涨近6%，截至发稿，涨5.94%，报16.23港元，成交额1880.74万港元。消息面上，12月30日，据科济药业官微消息，公司宣布，由旗下上海科济制药有限公司牵头申报的“实体肿瘤的免疫细胞治疗关键技术和 创新药 研发”项目，正式获批列入创新药物研发国家科技重大专项2025年度项目立项清单。据悉，国家科技重大专项是我国在战略前沿领域布局的最高层次科研...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1388505.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1161","symbol_name":"生物科技","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1388505.html","article_id":"2601071458","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601071458","pubTimestamp":1767583270,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，科济药业-B涨近6%，截至发稿，涨5.94%，报16.23港元，成交额1880.74万港元。消息面上，12月30日，据科济药业官微消息，公司宣布，由旗下上海科济制药有限公司牵头申报的“实体肿瘤的免疫细胞治疗关键技术和 创新药 研发”项目，正式获批列入创新药物研发国家科技重大专项2025年度项目立项清单。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1161":"生物科技","BK1587":"次新股","02171":"科济药业-B","BK1574":"生物医药B类股","BK1585":"昨日强势股"},"translate_title":"Changes in Hong Kong stocks | Keji Pharmaceutical-B (02171) rose nearly 6%. Recently, the new drug project for solid tumor immune cell therapy was included in a major national science and technology project","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02171":1.5},"content_text":"智通财经APP获悉，科济药业-B(02171)涨近6%，截至发稿，涨5.94%，报16.23港元，成交额1880.74万港元。消息面上，12月30日，据科济药业官微消息，公司宣布，由旗下上海科济制药有限公司牵头申报的“实体肿瘤的免疫细胞治疗关键技术和 创新药 研发”项目，正式获批列入创新药物研发国家科技重大专项2025年度项目立项清单。据悉，国家科技重大专项是我国在战略前沿领域布局的最高层次科研攻关计划，旨在实现关键核心技术的自主突破与产业转化。据介绍，本项目所属的“实体肿瘤的免疫细胞治疗新型药物研发”方向，将针对实体瘤治疗中存在的临床与科学瓶颈，系统推进新一代免疫细胞治疗的源头创新与技术攻关。项目将聚焦实体瘤免疫细胞治疗的前沿领域，着力开发具有突破性的治疗技术与创新产品，推动相关药物的临床转化与工程化制备体系建设。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2601071458","isCrawlerRequest":true}

港股异动 | 科济药业-B(02171)涨近6% 近日攻关实体瘤免疫细胞治疗新药 项目获列入国家科技重大专项

精彩评论

港股异动 | 科济药业-B(02171)涨近6% 近日攻关实体瘤免疫细胞治疗新药项目获列入国家科技重大专项